Sector consensus Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.25 CHF | -1.01% |
|
+4.62% | - |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 678.91 | +21.36% | 23 | ||||||
| 207 | +10.07% | 21 | ||||||
| 415.64 | +27.54% | 27 | ||||||
| 232 | +8.81% | 19 | ||||||
| 261,962.3 | +46.59% | 24 | ||||||
| 267.77 | +20.14% | 18 | ||||||
| 570.67 | -3.17% | 12 | ||||||
| 72.17 | +7.85% | 14 | ||||||
| 181.81 | +7.72% | 16 | ||||||
| 70 | -2.26% | 12 | ||||||
| 138.56 | +22.4% | 6 | ||||||
| 130.53 | -2.79% | 12 | ||||||
| 37.73 | -2.68% | 11 | ||||||
| 91.65 | +63.78% | 20 | ||||||
| 127.52 | +15.88% | 21 | ||||||
| 610.05 | +93.18% | 19 | ||||||
| 54.88 | +4.08% | 17 | ||||||
| 133.31 | -1.66% | 13 | ||||||
| 44.07 | +7.28% | 14 | ||||||
| Average | 14,001.4 | +18.11% | 17 | ||||||
| Weighted average by Cap. | 21,669.9 | +18.52% | 19 |
Select your edition
All financial news and data tailored to specific country editions
